TGA releases vaccine-related myocarditis severity details Fewer than 1% of all likely myocarditis or pericarditis cases linked to mRNA vaccines in Australia have been treated in intensive care.
TGA updates post-COVID vaccine myocarditis rates As many of Australia’s remaining vaccine-hesitant patients express concerns over rare side effects associated with mRNA vaccines, the TGA has broken down rates of myocarditis cases following Pfizer doses.
TGA monitoring overseas Moderna recommendations Several countries have limited the use of the mRNA vaccine in younger people, but there is no sign Australia will institute a similar pause.
Guillain-Barre Syndrome warning for AstraZeneca The TGA has updated the vaccine’s Product Information regarding the ‘very rare’ possibility of contracting the disorder.
TGA updates Pfizer vaccine side effect information Myocarditis and pericarditis were listed as official adverse reactions on the same day the vaccine was approved for use in children aged 12–15.